Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

UBC8 Activators

UBC8 Activators are chemical compounds that may indirectly enhance the functional activity of the E2 ubiquitin-conjugating enzyme UBC8. These compounds typically influence the ubiquitin-proteasome system (UPS), a critical pathway for protein degradation, in which UBC8 plays an integral part. UBC8 (Ubiquitin-conjugating enzyme 8) is a member of the E2 enzyme family that is involved in the ubiquitination pathway. Ubiquitination is a post-translational modification where ubiquitin, a small regulatory protein, is attached to substrate proteins, typically signaling them for degradation by the proteasome, although ubiquitination can also have non-degradative roles related to cellular signaling, DNA repair, and trafficking.

Direct UBC8 Activators interact with the enzyme in such a way as to boost its intrinsic ubiquitin-conjugating activity. This can be achieved by binding to the enzyme and inducing a conformational change that increases its affinity for ubiquitin or for the E1 ubiquitin-activating enzyme, thus facilitating the transfer of ubiquitin to UBC8. Alternatively, direct activators might increase the catalytic turnover rate of UBC8, accelerating the conjugation of ubiquitin to its substrate proteins. This type of activation is typically achieved by binding to the active site or to allosteric sites on the enzyme that regulate its activity. Indirect UBC8 Activators, on the other hand, would enhance UBC8 activity without binding directly to the enzyme. These might include chemicals that upregulate the expression of the UBC8 gene, thereby increasing the concentration of UBC8 in the cell. Other indirect activators could inhibit the action of deubiquitinating enzymes (DUBs) that remove ubiquitin from substrates, thus indirectly increasing the ubiquitination level of proteins within the cell. Additionally, compounds that modulate the activity or availability of E1 enzymes or E3 ubiquitin ligases, which work in concert with E2 enzymes like UBC8 in the ubiquitination cascade, could also serve as indirect activators.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide indirectly enhances the functional activity of UBC8 by promoting the degradation of transcription factors, which can indirectly increase the load of ubiquitinated proteins that UBC8 can process.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Lenalidomide, similar to Thalidomide, promotes the degradation of transcription factors, indirectly enhancing the functional activity of UBC8 by increasing the load of ubiquitinated proteins that UBC8 can process.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$100.00
$143.00
$312.00
$468.00
$1248.00
$1997.00
1
(1)

Pomalidomide is another immunomodulatory drug that enhances the degradation of transcription factors. This can indirectly enhance the functional activity of UBC8 by increasing the load of ubiquitinated proteins.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib inhibits the 26S proteasome and increases the load of ubiquitinated proteins, indirectly enhancing UBC8's activity by increasing the demand for its ubiquitination services.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Carfilzomib, like Bortezomib, inhibits the 26S proteasome, increasing the load of ubiquitinated proteins and indirectly enhancing the functional activity of UBC8.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 is a proteasome inhibitor that increases the load of ubiquitinated proteins, indirectly enhancing UBC8's activity by increasing the number of proteins that need ubiquitination.

Celastrol, Celastrus scandens

34157-83-0sc-202534
10 mg
$158.00
6
(1)

Celastrol is a proteostasis regulator that can increase the load of misfolded proteins, indirectly enhancing UBC8's activity by increasing the demand for its ubiquitination services.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin inhibits Hsp90, resulting in an increase in the load of misfolded proteins. This indirectly enhances UBC8's activity by increasing the demand for its ubiquitination services.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$130.00
$583.00
$4172.00
$20506.00
20
(1)

Withaferin A can cause protein misfolding, indirectly enhancing UBC8's activity by increasing the demand for its ubiquitination services.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, causing an increase in misfolded proteins. This indirectly enhances UBC8's activity by increasing the demand for its ubiquitination services.